Overview

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effect of desvenlafaxine administered as DVS SR on the pharmacokinetics of midazolam in healthy male and female subjects. The amount of drug in the body and the effect of the drug will also be evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Desvenlafaxine Succinate
Midazolam